Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

N Engl J Med. 2018 May 31;378(22):2141-2. doi: 10.1056/NEJMc1805135.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Rituximab*
  • Sulfonamides

Substances

  • Antineoplastic Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Rituximab
  • venetoclax